# EDGAR Filing Document

**Accession Number:** 0001753347
**File Stem:** 9999999995-26-000389
**Filing Date:** 2026-1
**Character Count:** 1342
**Document Hash:** c9e1eb41856a2f08d5213839f8f7ae21
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-26-000389.hdr.sgml**: 20260202

**ACCESSION NUMBER**: 9999999995-26-000389

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260130

**DATE AS OF CHANGE**: 20260202

**EFFECTIVENESS DATE**: 20260130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Edison Oncology Holding Corp
- **CENTRAL INDEX KEY:** 0001753347
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 831614120
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-291852
- **FILM NUMBER:** 26585502

**BUSINESS ADDRESS:**
- **STREET 1:** 3475 EDISON WAY
- **STREET 2:** SUITE R
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025
- **BUSINESS PHONE:** (650)690-1927

**MAIL ADDRESS:**
- **STREET 1:** 3475 EDISON WAY
- **STREET 2:** SUITE R
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** January 30, 2026

**Time:** 17:30:00

**Form Type:** S-1

---

**CIK:** 0001753347

**Company Name:** Edison Oncology Holding Corp

**File Number:** 333-291852